Related Experiment Videos
Sensorimotor gating and schizophrenia. Human and animal model studies
1Department of Psychiatry, University of California, San Diego, La Jolla 92093.
Archives of General Psychiatry
|February 1, 1990
Summary
Schizophrenia patients exhibit impaired sensorimotor gating, a deficit in central nervous system inhibition. Animal models reveal that altered dopamine and aminergic activity contribute to this gating failure, offering insights into the neurobiology of schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Behavioral Science
Background:
- Schizophrenia is associated with attentional abnormalities and monoaminergic alterations.
- Patients report sensory oversensitivity, potentially causing cognitive fragmentation.
- Impaired central nervous system inhibition, or sensorimotor gating, is observed in schizophrenia.
Purpose of the Study:
- To investigate the functional significance of attentional deficits and monoaminergic alterations in schizophrenia.
- To understand the neurobiological underpinnings of sensorimotor gating deficits in schizophrenia using human and animal models.
- To explore the temporal mapping of neuronal functions related to schizophrenia.
Main Methods:
- Utilizing paradigms such as cortical event-related potentials and prepulse inhibition of startle responses.
- Conducting human and animal model studies of sensorimotor gating.
- Analyzing the time course of deficits in relation to monoaminergic neuron function.
Main Results:
- Schizophrenic patients demonstrate impaired sensorimotor gating.
- Animal models with increased aminergic activity and dopamine tone exhibit sensorimotor gating failure.
- The temporal characteristics of deficits align with monoaminergic neuron activity patterns.
Conclusions:
- Sensorimotor gating studies provide insights into the neurobiology of schizophrenia spectrum disorders.
- These studies help elucidate the spatial and temporal mapping of neurons, trait/state deficits, and vulnerability factors.
- Translating attentional theories into testable hypotheses clarifies the neurobiology of schizophrenia.